Show Summary Details
Page of

Psychostimulants 

Psychostimulants
Chapter:
Psychostimulants
DOI:
10.1093/med/9780198714750.003.0014
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 14 December 2018

Chapter 14 of Addiction Medicine covers the range of psychostimulants including amphetamine-type substances such as amphetamine, methamphetamine, and methylene-dioxy-methamphetamine (MDMA), cocaine, mephedrone, and other synthetic stimulants and ephedrine. For each of the main types of stimulant there is an account of their epidemiology, mode of use, and pharmacological effects (including onset and duration of effect). Clinical syndromes are described in detail and include acute intoxication, overdose, withdrawal syndromes, and dependence. Detailed guidance is provided to help the clinical assessment of psychostimulant use disorders including clinical examination findings and urine drug screens. Detailed management protocols cover stimulant intoxication/overdose, withdrawal syndromes, neuropsychiatric complications, and stimulant dependence and other stimulant use disorders for the major groups of these drugs.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.